Enisamium Inhibits SARS-CoV-2 RNA Synthesis

Pandemic SARS-CoV-2 causes a mild to severe respiratory disease called coronavirus disease 2019 (COVID-19). While control of the SARS-CoV-2 spread partly depends on vaccine-induced or naturally acquired protective herd immunity, antiviral strategies are still needed to manage COVID-19. Enisamium is...

Descripción completa

Detalles Bibliográficos
Autores principales: Elli, Stefano, Bojkova, Denisa, Bechtel, Marco, Vial, Thomas, Boltz, David, Muzzio, Miguel, Peng, Xinjian, Sala, Federico, Cosentino, Cesare, Goy, Andrew, Guerrini, Marco, Müller, Lutz, Cinatl, Jindrich, Margitich, Victor, te Velthuis, Aartjan J. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467925/
https://www.ncbi.nlm.nih.gov/pubmed/34572438
http://dx.doi.org/10.3390/biomedicines9091254

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8467925/
https://www.ncbi.nlm.nih.gov/pubmed/34572438
http://dx.doi.org/10.3390/biomedicines9091254

Ejemplares similares